Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. L. Madden
Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A Phase I Pharmacokinetic and Biological Correlative Study of Oblimersen Sodium (Genasense, G3139), an Antisense Oligonucleotide to the BCL-2 mRNA, and of Docetaxel in Patients With Hormone-Refractory Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase II Study of Docetaxel and Irinotecan Combination Chemotherapy in Metastatic Gastric Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cationic Liposomes Loaded With Proapoptotic Peptided-(KLAKLAK)2and BCL-2 Antisense Oligodeoxynucleotide G3139 for Enhanced Anticancer Therapy
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
A Phase II Study of Docetaxel and Vinorelbine Plus Filgrastim for HER-2 Negative, Stage IV Breast Cancer: SWOG S0102
Breast Cancer Research and Treatment
Cancer Research
Oncology
Phase II Study of Docetaxel in Patients With Metastatic Pancreatic Cancer: A Japanese Cooperative Study
British Journal of Cancer
Cancer Research
Oncology
Multicenter Phase II Study of Docetaxel Plus Oxaliplatin Combination Chemotherapy in Patients With Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group
British Journal of Cancer
Cancer Research
Oncology
Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
